Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins

Journal of Immunology

Volumn 179, Issue 11, 2007, Pages 7254-7261

  Binder, Robert J ^a,c   Kelly III, John B ^b   Vatner, Ralph E ^b   Srivastava, Pramod K ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHAPERONE; EPITOPE; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HEAT SHOCK PROTEIN 90; HLA ANTIGEN CLASS 1; PEPTIDE; SARCOMA GLYCOPROTEIN GP96 REJECTION ANTIGENS; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BETA-GALACTOSIDASE; CELL LINE; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HSP90 HEAT-SHOCK PROTEINS; MICE; MICE, INBRED C57BL; PEPTIDES;

EID: 38849166048     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.11.7254     Document Type: Article

References (35)

1. P. Srivastava. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20: 395-425.
2. Srivastava, P. K., and M. R. Das. 1984. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int. J. Cancer. 33: 417-422.
3. Srivastava, P. K., A. B. DeLeo, and L. J. Old. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83: 3407-3411.
4. Srivastava, P. K., and M. Heike. 1991. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin. Immunol. 3: 57-64.
5. Srivastava, P. K., and R. G. Maki. 1991. Stress-induced proteins in immune response to cancer. Curr. Top. Microbiol. Immunol. 167: 109-123.
6. Nieland, T. J., M. C. Tan, M. Monne-van Muijen, F. Koning, A. M. Kruisbeek, and G. M. van Bleek. 1996. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. USA 93: 6135-6139.
7. Suto, R., and P. K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1588.
8. Navaratnam, M., M. S. Deshpande, M. J. Hariharan, D. S. Zatechka, Jr., and S. Srikumaran. 2001. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1. Vaccine 19: 1425-1434.
9. Ishii, T., H. Udono, T. Yamano, H. Ohta, A. Uenaka, T. Ono, A. Hizuta, N. Tanaka, P. K. Srivastava, and E. Nakayama. 1999. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162: 1303-1309.
10. Zugel, U., A. M. Sponaas, J. Neckermann, B. Schoel, and S. H. Kaufmann. 2001. 96-peptide vaccination of mice against intracellular bacteria. Infect. Immun. 69: 4164-4167.
11. b-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96. Eur. J. Immunol. 28: 1016-1021.
12. Arnold, D., S. Faath, H. Rammensee, and H. Schild. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182: 885-889.
13. Castelli, C., A. M. Ciupitu, F. Rini, L. Rivoltini, A. Mazzocchi, R. Kiessling, and G. Parmiani. 2001. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res. 61: 222-227.
14. Parmiani, G., A. De Filippo, L. Pilla, C. Castelli, and L. Rivoltini, L. 2006. Heat shock proteins gp96 as immunogens in cancer patients. Int. J. Hyperthermia 22: 223-227.
15. Noessner, E., R. Gastpar, V. Milani, A. Brandl, P. J. Hutzler, M. C. Kuppner, M. Roos, E. Kremmer, A. Asea, S. K. Calderwood, and R. D. Issels. 2002. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J. Immunol. 169: 5424-5432.
16. + T cells. Nat. Immunol. 6: 593-999.
17. Zhu, X., X. Zhao, W. F. Burkholder, A. Gragerov, C. M. Ogata, M. E. Gottesman, and W. A. Hendrickson. 1996. Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272: 1606-1614.
18. MacAry, P. A., B. Javid, R. A. Floto, K. G. Smith, W. Oehlmann, M. Singh, and P. J. Lehner. 2004. HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation. Immunity 20: 95-106.
19. Vogen, S., T. Gidalevitz, C. Biswas, B. B. Simen, E. Stein, F. Gulmen, and Y. Argon. 2002. Radicicol-sensitive peptide binding to the N-terminal portion of GRP94. J. Biol. Chem. 277: 40742-40750.
20. Linderoth, N. A., A. Popowicz, and S. Sastry. 2000. Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94). J. Biol. Chem. 275: 5472-5477.
21. Baker-LePain, J. C., M. Sarzotti, T. A. Fields, C. Y. Li, and C. V. Nicchitta. 2002. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J. Exp. Med. 196: 1447-1459.
22. Baker-LePain, J. C., R. C. Reed, and C. V. Nicchitta. 2003. ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. Curr. Opin. Immunol. 15: 89-94.
23. Nicchitta, C. V., D. M. Carrick, and J. C. Baker-Lepain. 2004. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity. Cell Stress Chaperones 9: 325-331.
24. Yewdell, J. W. 2005. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol. Rev. 207: 8-18.
25. Campbell, D. J., T. Serwold, and N. Shastri. 2000. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules. J. Immunol. 164: 168-175.
26. Chandawarkar, R. Y., M. S. Wagh, and P. K. Srivastava. 1999. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189: 1437-1442.
27. Blachere, N E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186: 1315-1322.
28. Udono, H., and P. K. Srivastava. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152: 5398-5403.
29. Tamura, Y., P. Peng, K. Liu, M. Daou, and P. K. Srivastava. 1997. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278: 117-120.
30. Berwin, B., R. C. Reed, and C. V. Nicchitta. 2001. Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96. J. Biol. Chem. 276: 21083-21088.
31. Shen, L., and K. L. Rock. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101: 3035-3040.
32. Kunisawa, J., and N. Shastri. 2003. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol. Cell 12: 565-576.
33. Kunisawa, J., and N. Shastri. 2006. Hsp90α chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 24: 523-534.
34. Srivastava, P. K., H. Udono, N. E. Blachere, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39: 93-98.
35. Binder, R. J., N. E. Blachere., and P. K. Srivastava. 2001. Heat shock protein+chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276: 17163-17171.